Global Carotid Ultrasound Imaging Market Segmentation, By Indication (Stroke, Congestive Heart Failure, Arrhythmias, and Other Disease Indication), End User (Hospital, Diagnostic Centers, Ambulatory Care Centers, and Others) – Industry Trends and Forecast to 2032
Carotid Ultrasound Imaging Market Analysis
The carotid ultrasound imaging market is experiencing significant growth due to advancements in technology, increasing prevalence of cardiovascular diseases, and heightened awareness about early detection. This non-invasive imaging technique is vital for assessing carotid artery health and preventing strokes, which are among the leading causes of death globally. Recent innovations include the integration of artificial intelligence (AI) to improve image accuracy, streamline analysis, and provide real-time diagnostic support, enhancing both patient outcomes and workflow efficiency for healthcare providers. Advanced ultrasound devices now offer high-resolution imaging and enhanced capabilities, allowing for detailed assessments of plaque build-up and blood flow abnormalities. In addition, the development of portable and handheld ultrasound units has expanded access to care, especially in remote and underserved regions. Governments and healthcare organizations are investing in public health initiatives that promote preventive screening, further fueling the demand for reliable diagnostic tools. The combination of cutting-edge technology, increased awareness of stroke prevention, and investment in healthcare infrastructure collectively drive the growth of the carotid ultrasound imaging market, paving the way for better diagnosis and management of vascular diseases.
Carotid Ultrasound Imaging Market Size
The global carotid ultrasound imaging market size was valued at USD 899.10 million in 2024 and is projected to reach USD 1343.63 million by 2032, with a CAGR of 5.15% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Carotid Ultrasound Imaging Market Trends
“Increasing Integration Artificial Intelligence (AI)”
A significant trend in the carotid ultrasound imaging market is the integration of artificial intelligence (AI) to enhance diagnostic accuracy and efficiency. AI-powered ultrasound systems are revolutionizing the way healthcare providers assess carotid artery health by automating image analysis and identifying potential risks such as plaque build-up with greater precision. For Instance, companies such as Philips and Siemens Healthineers are incorporating AI algorithms into their ultrasound devices to enable faster, more consistent readings, reducing the potential for human error. This technology speeds up diagnosis and aids in predicting stroke risk, allowing for timely intervention and personalized treatment plans. The rise of AI in the carotid ultrasound market is driven by the increasing need for accurate, efficient diagnostics in the face of rising cardiovascular disease rates. This trend positions AI-enhanced ultrasound as a critical tool for preventive care, improving patient outcomes and boosting healthcare efficiency overall.
Report Scope and Carotid Ultrasound Imaging Market Segmentation
|
Attributes
|
Carotid Ultrasound Imaging Key Market Insights
|
|
Segments Covered
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
GENERAL ELECTRIC (U.S.), Siemens (Germany), Hitachi Ltd (Japan), Koninklijke Philips N.V. (Netherlands), CANON MEDICAL SYSTEMS CORPORATION (Japan), Esaote SPA (Italy), SAMSUNG (South Korea), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), FUJIFILM Corporation (Japan), KPI Healthcare India Pvt Ltd (India), Whale Imaging (South Korea), ultrasoundtechnologies (U.S.), Unetixs Vascular, Inc. (U.S.), SuperSonic Imagine (France), Trivitron Healthcare (India), Atys Medical (France), Medtronic (U.S.), Stryker (U.S.), Boston Scientific Corporation (U.S.), Abbott (U.S.), and Cardinal Health (U.S.)
|
|
Market Opportunities
|
|
|
Value Added Data Infosets
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Carotid Ultrasound Imaging Market Definition
Carotid ultrasound imaging is a non-invasive diagnostic procedure that uses high-frequency sound waves to create detailed images of the carotid arteries, which are the major blood vessels supplying blood to the brain. This imaging technique is primarily used to assess the health of these arteries, detect any narrowing or blockages due to plaque build-up, and evaluate blood flow. By identifying conditions such as atherosclerosis, stenosis, or other vascular abnormalities, carotid ultrasound helps in predicting the risk of stroke and guiding preventive treatment plans.
Carotid Ultrasound Imaging Market Dynamics
Drivers
- Increasing Prevalence of Cardiovascular Diseases
The increasing prevalence of cardiovascular diseases is a major driver for the growth of the carotid ultrasound imaging market. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for an estimated 17.9 million deaths each year, or 32% of all deaths worldwide. Atherosclerosis, a condition marked by plaque build-up in the arteries, is a primary contributor to stroke and heart attacks. The U.S. Centers for Disease Control and Prevention (CDC) reports that nearly 805,000 Americans experience a stroke annually, emphasizing the critical need for early detection and intervention. Carotid ultrasound is a non-invasive, effective diagnostic tool for detecting early signs of artery narrowing and plaque build-up, allowing for timely medical management and prevention of severe outcomes. This rising demand for early and accurate detection of cardiovascular risk factors is driving the carotid ultrasound imaging market, as healthcare providers seek reliable solutions to address the growing burden of vascular diseases.
- Rising Aging Global Population
The aging global population is a significant driver for the carotid ultrasound imaging market, as older adults are more prone to vascular diseases, including atherosclerosis and other conditions that increase the risk of stroke. According to the United Nations, the number of people aged 60 and over is expected to reach 2.1 billion by 2050, nearly doubling from 1 billion in 2020. This demographic shift means that healthcare systems worldwide are facing an increased demand for preventive screenings and diagnostic tools that can help manage age-related cardiovascular risks. Carotid ultrasound imaging is particularly valuable in this context because it offers a non-invasive, efficient way to assess arterial health, identify early signs of plaque buildup, and monitor blood flow. As the elderly population grows and their susceptibility to vascular conditions increases, the need for reliable diagnostic solutions such as carotid ultrasound imaging is driving market expansion and innovation in healthcare services aimed at improving longevity and quality of life.
Opportunities
- Growing Awareness about Stroke Prevention
Growing awareness about stroke prevention and the importance of early detection has created a significant market opportunity for carotid ultrasound imaging. Public health campaigns and educational initiatives by organizations such as the American Heart Association (AHA) have raised awareness about the importance of vascular health and the role of routine screenings in preventing strokes. For instance, community health programs often promote carotid ultrasound as a preventive measure, encouraging individuals, especially those with risk factors such as hypertension and diabetes, to undergo regular checks. This increase in public awareness has led to higher adoption rates of carotid ultrasound for routine check-ups and screenings in clinical settings. The growing focus on preventive healthcare and early intervention is driving the demand for reliable, non-invasive diagnostic tools such as carotid ultrasound. As more people prioritize their vascular health and seek proactive measures, healthcare providers are expanding their services to include carotid ultrasound, presenting a significant market opportunity for companies developing and distributing these diagnostic solutions.
- Increasing Government and Healthcare Investments
Government and healthcare investments in cardiovascular health programs and diagnostic infrastructure are playing a crucial role in driving the growth of the carotid ultrasound imaging market. For Instance, the U.S. government has supported public health initiatives such as the Million Hearts® program, which aims to prevent 1 million heart attacks and strokes by 2027 through strategies that include promoting early detection and preventive screenings. Similarly, European countries have integrated national screening programs for vascular health, encouraging the use of diagnostic tools such as carotid ultrasound to identify at-risk populations and prevent severe cardiovascular events. These investments enhance access to essential diagnostic services, making it easier for healthcare providers to adopt carotid ultrasound technology. The increased allocation of funds to cardiovascular health and the push for early detection contribute to market growth, creating significant opportunities for companies that develop, produce, and distribute carotid ultrasound imaging solutions, as they align with public health objectives aimed at reducing stroke and heart disease incidence.
Restraints/Challenges
- High Equipment Costs
High equipment costs are a significant challenge in the carotid ultrasound imaging market, as they limit access to advanced diagnostic technology for many healthcare providers, particularly smaller clinics and facilities in regions with budget constraints. For instance, a state-of-the-art carotid ultrasound machine can cost tens of thousands of dollars, and the expenses do not stop there; ongoing maintenance, software updates, and specialized training for staff add to the financial burden. This high price point can prevent smaller or rural healthcare centers from investing in such equipment, forcing them to either rely on less advanced technology or refer patients to larger, better-funded facilities. As a result, this challenge impacts the overall accessibility and adoption of carotid ultrasound imaging, hindering early diagnosis and treatment of vascular diseases and limiting market growth. To tackle this issue, manufacturers may need to explore cost-reduction strategies, offer financing options, or develop more affordable models without compromising on essential capabilities.
- Shortage of Skilled Professionals
The shortage of skilled professionals is a major challenge in the carotid ultrasound imaging market, as it limits the efficient use of these diagnostic tools and impacts patient care. Proper interpretation of carotid ultrasound images requires specialized training and expertise that not all medical professionals possess. For Instance, a study in certain healthcare settings has shown that radiologists or sonographers with advanced skills in carotid imaging are in short supply, leading to delays in diagnosis and increased reliance on more experienced, often overburdened, and specialists. This shortage can affect healthcare facilities’ ability to use ultrasound technology effectively and may lead to an underutilization of available equipment. In addition, continuous advancements in imaging technology require ongoing education, which can be difficult for some professionals to access or afford. This limits the growth of the market, as well-trained practitioners are essential for maintaining high standards of care and ensuring the technology is used to its full potential. Addressing this challenge involves investing in targeted training programs and educational initiatives to expand the pool of skilled workers.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Carotid Ultrasound Imaging Market Scope
The market is segmented on the basis of indication and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Indication
- Stroke
- Congestive Heart Failure
- Arrhythmias
- Other Disease Indication
End User
- Hospital
- Diagnostic Centers
- Ambulatory Care Centers
- Others
Carotid Ultrasound Imaging Market Regional Analysis
The market is analysed and market size insights and trends are provided by country, indication, and end user as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America leads the carotid ultrasound imaging market due to significant investments in research and development by numerous medical device companies, fostering innovation and technological advancements. The region's robust healthcare infrastructure and well-established reimbursement policies further contribute to the market's growth, making advanced imaging solutions more accessible to healthcare providers and patients. In addition, the presence of leading industry players and the adoption of cutting-edge ultrasound technology have bolstered market expansion. This combination of strong R&D efforts, supportive policies, and technological adoption positions North America as a dominant force in the carotid ultrasound imaging sector.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Carotid Ultrasound Imaging Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Carotid Ultrasound Imaging Market Leaders Operating in the Market Are:
- GENERAL ELECTRIC (U.S.)
- Siemens (Germany)
- Hitachi Ltd (Japan)
- Koninklijke Philips N.V. (Netherlands)
- CANON MEDICAL SYSTEMS CORPORATION (Japan)
- Esaote SPA (Italy)
- SAMSUNG (South Korea)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China)
- FUJIFILM Corporation (Japan)
- KPI Healthcare India Pvt Ltd (India)
- Whale Imaging (South Korea)
- ultrasoundtechnologies (U.S.)
- Unetixs Vascular, Inc. (U.S.)
- SuperSonic Imagine (France)
- Trivitron Healthcare (India)
- Atys Medical (France)
- Medtronic (U.S.)
- Stryker (U.S.)
- Boston Scientific Corporation (U.S.)
- Abbott (U.S.)
- Cardinal Health (U.S.)
Latest Developments in Carotid Ultrasound Imaging Market
- In June 2024, Canon Medical Systems Korea announced the launch of its latest ultrasound device, the Aplio me, following its recent domestic approval. The Aplio me is designed to be an all-in-one ultrasound system that incorporates advanced AI technology, enhancing user convenience and efficiency, particularly in busy clinical environments that require extensive patient scanning
- In January 2024, Canon Medical Systems partnered with Olympus to introduce the Aplio i800 EUS, a hybrid ultrasound system. This advanced device is especially effective for detecting small lesions in the pancreas, as noted by Akihiro Sano, General Manager of Ultrasound Systems at Canon Medical Systems Corporation
- In July 2022, Siemens Healthineers showcased its updated Acuson family at the European Congress of Radiology (ECR) in Vienna. This refreshed ultrasound portfolio was designed to increase clinical adaptability and address challenges in various medical applications. The new lineup includes 12 new transducers across four ultrasound systems and expanded AI-powered tools, aimed at enhancing efficiency and consistency for clinicians. The systems are ideal for routine clinical use and research, offering diverse solutions to improve access to care
- In April 2021, Imageens SAS secured USD 1.4 million in seed funding to further develop its two artificial intelligence (AI) solutions in the field of medical imaging in Europe. The first product, Artfun+, is an AI software application designed to anticipate cardiovascular issues through new prognostic biomarkers. The second product, Label, is an algorithm that automatically classifies and evaluates medical imaging data
- In February 2021, Piur Imaging launched its remote image analysis platform, Piur Remote Expert, targeted at research users. This solution enables remote analysis of tomographic three-dimensional (3D) ultrasound images, including carotid plaque assessments and abdominal aortic aneurysm (AAA) volume measurements
SKU-